Insulin Pumps
- PMID: 32069156
- PMCID: PMC7207015
- DOI: 10.1089/dia.2020.2502
Insulin Pumps
Conflict of interest statement
R.L. has research support from the NIDDK (1K12DK122550) and Stanford Maternal Child Health Research Institute. Dr. Lal has consulted for GlySens Incorporated and Abbott Diabetes Care. L.L. reports having received speaker honoraria from Animas, Abbott, Insulet, Medtronic, Novo Nordisk, Roche, and Sanofi. Advisory panel for Animas, Abbott, Novo Nordisk, Dexcom, Medtronic, Sanofi, and Roche. Research support from Novo Nordisk and Dexcom.
References
-
- Yeoh E, Beato-Vibora P, Rogers H, Amiel SA, Choudhary P. Efficacy of insulin pump therapy in elderly patients. Diabetes Technol Ther 2015; 17: 364–365 - PubMed
-
- Yeh HC, Brown TT, Naruthur N, et al. . Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med 2012; 157: 336–347 - PubMed
-
- Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 2010: CD005103. - PubMed
-
- Zhou C, Yool AJ, Byard RW. Armanni-Ebstein lesions in terminal hyperglycemia. J Forensic Sci 2017; 62: 921–925 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical